Item 1A. Risk Factors

Certain factors may have a material adverse effect on our business, financial condition, results of operations and cash flows, and you should carefully consider them. It is not possible to predict or identify all such factors. For a discussion of potential risks or uncertainties affecting us, please refer to the information under the heading “Item 1A—Risk Factors” in our 2025 Annual Report. Additional risks and uncertainties that are not yet identified or that we currently believe to be immaterial may also materially harm our business, financial condition, results of operations and cash flows.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities:


(In millions, except number of shares and per share amounts)
Period in 2026	Total Number of Shares Purchased	Average Price Paid Per Share		Total Number of Shares Purchased as Part of Publicly Announced Programs (1)	Approximate Dollar Value of Shares that May Yet be Purchased Under the Programs (1)
January 1 - January 31	101,291	$	236.66	101,291	$	750.7
February 1 - February 28	139,837	227.19		139,837	718.9
March 1 - March 31	315,009	219.79		315,009	649.7
Total	556,137	$	224.73	556,137	$	649.7

(1)Shares repurchased pursuant to the November 2023 and November 2025 publicly announced share repurchase authorizations of up to $600.0 million and $700.0 million aggregate cost at purchase of outstanding common stock, respectively. As of March 31, 2026, $649.7 million aggregate cost at purchase remained unused under the November 2025 repurchase authorization.

Previous: Item 1. Legal Proceedings · Next: Item 5. Other Information